Ajanta Pharma Ltd - AJANTA PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE031B01049
₹ 2,113.10 (-0.11%) icon21 Feb, 2024, 4:12:30 PM
Open
₹ 2,128.00
Prev. Close
₹ 2,115.40
Turnover(lac)
₹ 0.02
Day's High
₹ 2,156.70
Day's Low
₹ 2,099.65
52 Wk High
₹ 2,353.95
52 Wk Low
₹ 1,131.70
Book Value
₹ 309.01
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 26,607.45
P/E
34.96
EPS
60.50
Div. Yield
0.33

Ajanta Pharma Ltd Stock View

info icon
Edit Image
Target | 18 Feb, 2024 2,074.54 (-1.24%)

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic ... Read More

Ajanta Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/21/2024 4:12:30 PM

    ₹ 2113.1 -2.30 -0.11
  • Open
  • ₹ 2,128
  • Prev. Close
  • ₹ 2,115.4
  • Turnover(Lac.)
  • ₹ 1,503
  • Day's High
  • ₹ 2,156.7
  • Day's Low
  • ₹ 2,099.65
  • 52 Week's High
  • ₹ 2,353.95
  • 52 Week's Low
  • ₹ 1,131.7
  • Book Value
  • ₹ 309.01
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 26,607.45
  • P/E
  • 34.96
  • EPS
  • 60.5
  • Divi. Yield
  • 0.33

Ajanta Pharma Ltd Corporate Actions

31 Jan , 2024

12:00 AM

Dividend

Dividend amount: 26
Announcement date: 31 Jan , 2024

View Details

19 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2024

12:00 AM

19 Oct , 2023

12:00 AM

19 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

Dividend

Dividend amount: 15
Announcement date: 28 Jul , 2023

View Details

28 Jul , 2023

12:00 AM

Dividend

Dividend amount: 10
Announcement date: 28 Jul , 2023

View Details

14 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

29 May , 2023

12:00 AM

AGM

Announcement date: 29 May , 2023

View Details

27 Apr , 2023

12:00 AM

27 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Ajanta Pharma Ltd News and Update

Image not found
  • 19 February, 2024 |
  • 12:02 AM

The Bank Nifty surged by nearly 200 points to around 46,572 levels, led by gains in Bandhan Bank, ICICI Bank, and AU Small Finance Bank.

Image not found
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Ajanta Pharma Ltd SHAREHOLDING SNAPSHOT
21 February , 2024 | 04:32 PM

PROMOTER - TOTAL66.21%

Indian: 66.21%

Foreign: 0%

NON-PROMOTER - TOTAL 33.79%

Institutions: 25.78%

Non-Institutions: 8.01%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Ajanta Pharma Ltd FINANCIALS

Ajanta Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Ajanta Pharma Ltd

  • Mannalal B Agrawal
  • Chairman (Non-Executive)
  • Madhusudan B Agrawal
  • Vice Chairman
  • Yogesh Agrawal
  • Managing Director
  • Chandrakanth M Khetan
  • Independent Director
  • Gaurang Shah
  • Vice President & CS
  • Rajesh M Agrawal
  • Joint Managing Director
  • K H Viswanathan
  • Independent Director
  • Prabhakar Dalal
  • Independent Director
  • Anjana Grewal
  • Independent Director

Summary

Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa. The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets. It produces a comprehensive range of specialty products targeting different therapeutic segments. It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The companys business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. In India, the Company has presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management.In branded generic business in emerging markets in Asia and Africa, Ajanta Pharmas products cater to therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products. The companys institutional business comprises of supplies to various government bodies in India and supply of Anti-Malarial products under WHO approved programs in Africa.Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India and... Read More


Reports by Ajanta Pharma Ltd


Reports by Ajanta Pharma Ltd

Company FAQ

No Record Found